JPMorgan reinstates British American Tobacco stock coverage with overweight rating
JPMorgan reinstated coverage on British American Tobacco (BTI) with an overweight rating and a GBP53.00 price target. The firm cited strong growth prospects and attractive valuation, expecting 3-5% like-for-like growth in 2027. Goldman Sachs also upgraded BTI to Buy, noting a clear growth inflection story. The stock trades at a P/E ratio of 15.4 and offers a 5.5% dividend yield.
How this was made
The 30-second read
Why it matters
The upgrade may trigger short‑term buying and raise the stock toward the new target, especially in pre‑market trading.
Market read
Analyst coverage change is a primary catalyst for BTI, potentially influencing sector peers.
What to watch
Potential regulatory headwinds on nicotine pouches and currency risk for GBP‑denominated target.
Background
JPMorgan previously removed coverage; reinstating it signals renewed confidence in BTI's growth outlook.
Ticker impact
JPMorgan reinstated coverage on British American Tobacco with an overweight rating and a GBP53 price target, marking a fresh analyst upgrade.
likely upward pressure as investors price in the overweight rating and higher target.
The rating change and target are new information that can move the stock immediately.
Market effects
May lift sentiment across the tobacco sector as peers could be re‑rated.
Positive for UK‑listed consumer staples and for US investors holding BTI ADRs.
Limited to tobacco and consumer‑staples investors worldwide.
Counterpoint
The rating could be premature if growth assumptions for vapor products falter.
Key entities
- analystJPMorgan
Equity research firm providing the overweight rating and price target.
- companyBritish American Tobacco
Global tobacco producer listed on NYSE under BTI.
